Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Continuous cell lines from the Muscovy duck as potential replacement for primary cells in the production of avian vaccines.

Jordan I, John K, Höwing K, Lohr V, Penzes Z, Gubucz-Sombor E, Fu Y, Gao P, Harder T, Zádori Z, Sandig V.

Avian Pathol. 2016;45(2):137-55. doi: 10.1080/03079457.2016.1138280.

PMID:
26814192
2.

The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis.

Lohr V, Hädicke O, Genzel Y, Jordan I, Büntemeyer H, Klamt S, Reichl U.

BMC Biotechnol. 2014 Jul 30;14:72. doi: 10.1186/1472-6750-14-72.

3.

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

Jordan I, Lohr V, Genzel Y, Reichl U, Sandig V.

Microorganisms. 2013 Nov 1;1(1):100-121. Review.

4.

Evaluating differences of metabolic performances: statistical methods and their application to animal cell cultivations.

Hädicke O, Lohr V, Genzel Y, Reichl U, Klamt S.

Biotechnol Bioeng. 2013 Oct;110(10):2633-42. doi: 10.1002/bit.24926. Epub 2013 Apr 30.

PMID:
23568808
5.

Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.

Lohr V, Genzel Y, Jordan I, Katinger D, Mahr S, Sandig V, Reichl U.

BMC Biotechnol. 2012 Oct 30;12:79. doi: 10.1186/1472-6750-12-79.

6.

Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture.

Petiot E, Jacob D, Lanthier S, Lohr V, Ansorge S, Kamen AA.

BMC Biotechnol. 2011 Sep 1;11:84. doi: 10.1186/1472-6750-11-84.

7.

A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor.

Lohr V, Genzel Y, Behrendt I, Scharfenberg K, Reichl U.

Vaccine. 2010 Aug 31;28(38):6256-64. doi: 10.1016/j.vaccine.2010.07.004. Epub 2010 Jul 16.

PMID:
20638458
8.

New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation.

Lohr V, Rath A, Genzel Y, Jordan I, Sandig V, Reichl U.

Vaccine. 2009 Aug 6;27(36):4975-82. doi: 10.1016/j.vaccine.2009.05.083. Epub 2009 Jun 14.

PMID:
19531390
9.

Supplemental Content

Support Center